New LabPatch could replace finger pricks for diabetes patients

NCT ID NCT05754281

Ongoing Diagnosis Sponsor: Joslin Diabetes Center Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new device called LabPatch that measures blood sugar from fluid just under the skin. About 60 adults with type 1 or type 2 diabetes who use insulin will wear the patch for 6 hours. Researchers will compare its readings to standard lab tests and two commercial glucose meters to see how accurate it is.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: LabPatch glucose sensing system (a device that measures glucose from interstitial fluid)
What this could lead to: If accurate, this device could offer a less invasive way for people with diabetes to monitor their blood sugar levels.
What could go wrong: This is a small, early-stage study focused on accuracy, not on improving health outcomes. The device may not prove reliable enough for everyday use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES MELLITUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 1 diabetes mellitus type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TYPE 1 DIABETES MELLITUS TYPE 2 DIABETES MELLITUS

Contacts and locations

Locations

Joslin Diabetes Center

Boston, Massachusetts, 02215, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.